title: Genistein inhibits constitutive and inducible NFkappaB activation and decreases IL-8 production by human cystic fibrosis bronchial gland cells.
abstract: The inflammatory pathogenesis in airways of patients with cystic fibrosis (CF) is still unresolved. We demonstrate here that in in situ human DeltaF508 homozygous CF bronchial tissues, submucosal gland cells exhibit an absence of inhibitor factor kappaBalpha (IkappaBalpha) and high levels of chemokine interleukin-8 (IL-8) expression. These results were confirmed by cultured human CF bronchial gland cells in which a lack of cytosolic IkappaBalpha and high levels of constitutively activated nuclear factor kappaB (NFkappaB) associated with an up-regulation of IL-8 production (13-fold increase) were found when compared to non-CF (control) disease bronchial gland cells. We also demonstrated that the isoflavone genistein, a well known CFTR mutant Cl(-) channel stimulator, significantly reduces the endogenous and Pseudomonas aeruginosa lipopolysaccharide-induced IL-8 production in cultured CF bronchial gland cells by increasing cytosolic IkappaBalpha protein levels. Overall, results show that genistein is a potent inhibitor of the activated NFkappaB identified in CF gland cells. This strong inhibition of constitutively activated NFkappaB and the resulting down-regulation of IL-8 production by genistein in the CF gland cells highlights the key role played by cytosolic IkappaBalpha in the regulation of inflammatory processes in CF human airway cells.
authors.affiliation: INSERM Unité 514,(*) Reims Hôpital Broussais, Paris Hôpital Cochin, Paris, France.
authors.forename: O
authors.initials: O
authors.lastname: Tabary
authors.forename: S
authors.initials: S
authors.lastname: Escotte
authors.forename: J P
authors.initials: JP
authors.lastname: Couetil
authors.forename: D
authors.initials: D
authors.lastname: Hubert
authors.forename: D
authors.initials: D
authors.lastname: Dusser
authors.forename: E
authors.initials: E
authors.lastname: Puchelle
authors.forename: J
authors.initials: J
authors.lastname: Jacquot
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D001980:Bronchi / Q000187:drug effects* / Q000378:metabolism*; D002467:Cell Nucleus / Q000378:metabolism; D002478:Cells, Cultured; D002648:Child; D003550:Cystic Fibrosis / Q000378:metabolism*; D004305:Dose-Response Relationship, Drug; D004791:Enzyme Inhibitors / Q000494:pharmacology; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D019833:Genistein / Q000494:pharmacology*; D006801:Humans; D007150:Immunohistochemistry; D016209:Interleukin-8 / Q000096:biosynthesis*; D008070:Lipopolysaccharides / Q000494:pharmacology; D016040:Lung Transplantation; D008297:Male; D008875:Middle Aged; D016328:NF-kappa B / Q000032:analysis / Q000037:antagonists & inhibitors / Q000378:metabolism*; D011550:Pseudomonas aeruginosa / Q000378:metabolism; D013997:Time Factors
chemical_list: D004791:Enzyme Inhibitors; D016209:Interleukin-8; D008070:Lipopolysaccharides; D016328:NF-kappa B; D019833:Genistein